---
layout: minimal-medicine
title: Toborinone
---

# Toborinone
### Generic Name
Toborinone

### Usage
Toborinone is a phosphodiesterase-III inhibitor with moderate coronary vasodilatory effects.  While it showed promise in treating heart failure, its development was discontinued after Phase III clinical trials.  This means it is not currently available for prescription or over-the-counter use.  The information below is for educational purposes only and should not be interpreted as a recommendation for use.

### Dosage
Because toborinone is not currently available for use, no dosage information can be provided.  Any information found elsewhere should be treated with extreme caution, as it may be outdated or inaccurate.

### Side Effects
Since toborinone did not progress to market approval, a complete profile of side effects in humans is unavailable.  However, based on pre-clinical and early clinical trials, potential side effects *might* have included (but are not limited to):  This list is not exhaustive and should not be considered definitive.

*   Cardiac arrhythmias
*   Changes in blood pressure
*   Headache
*   Gastrointestinal disturbances


**Important Note:** This is not a comprehensive list.  If toborinone were ever to be reintroduced, further research would be needed to fully characterize the potential side effects.

### How it Works
Toborinone works primarily by inhibiting phosphodiesterase-III (PDE-III). This enzyme normally breaks down cyclic adenosine monophosphate (cAMP), a crucial molecule involved in regulating calcium levels within heart muscle cells. By inhibiting PDE-III, toborinone increases cAMP levels, leading to an increase in intracellular calcium. This rise in calcium enhances the contractility of the heart muscle (positive inotropic effect), making it pump more effectively.  Additionally, toborinone has minor effects on heart rate (positive chronotropic effect) and may also affect potassium channels within the heart.

### Precautions
Given that toborinone is not currently marketed, detailed precautions cannot be definitively provided. However, potential precautions based on its mechanism of action and class of drugs *might* have included:

*   **Cardiac conditions:**  Patients with certain heart conditions (e.g., severe arrhythmias, hypertrophic cardiomyopathy) might be at increased risk of adverse events.
*   **Interactions with other medications:** Toborinone, like other phosphodiesterase inhibitors, might interact with other drugs affecting the heart or affecting cAMP metabolism.
*   **Pregnancy and breastfeeding:**  The effects on pregnancy and breastfeeding would need to be thoroughly investigated before considering use.
*   **Older adults and children:** Special considerations regarding dosage and monitoring might be necessary in these populations.

**Important Note:**  This section is speculative, based on the known actions of the drug.  Actual precautions would need to be established through further clinical research if toborinone were ever to be re-introduced.


### FAQs
Because toborinone is not currently available,  the following FAQs are based on hypothetical use.

**Q: Where can I get toborinone?**

A: Toborinone is not currently available for prescription or purchase.

**Q: Is toborinone safe?**

A: The safety profile of toborinone is not fully established as it did not complete clinical development.  Its use would depend on further research and regulatory approvals.

**Q:  What are the long-term effects of toborinone?**

A:  Long-term effects are unknown because the drug did not reach the market.

**Q: Are there any alternatives to toborinone?**

A:  Yes, other medications are available for heart failure. Consult a cardiologist to discuss appropriate treatment options.


**Disclaimer:** This information is for educational purposes only and should not be considered medical advice. Always consult a healthcare professional for any health concerns or before making any decisions related to your health or treatment.
